C132H178F3N29O6 — CID 157320784
5-[2-cyclobutyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-cyclopentyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;bis(3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine);4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine (PubChem CID 157320784) has the molecular formula C132H178F3N29O6 and a molecular weight of 2324.07 g/mol. Its IUPAC name is 5-[2-cyclobutyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-cyclopentyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;bis(3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine);4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine.
| Compound Name | 5-[2-cyclobutyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-cyclopentyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;bis(3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine);4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine |
|---|---|
| PubChem CID | 157320784 |
| Molecular Formula | C132H178F3N29O6 |
| Molecular Weight | 2324.07 g/mol |
| Exact Mass | 2322.45 |
| IUPAC Name | 5-[2-cyclobutyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-cyclopentyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;bis(3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine);4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine |
| SMILES | CCc1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CCC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(C3CCCC3)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cnc1N.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cnc1N.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cc1C(F)(F)F |
| InChI | InChI=1S/C23H29F3N4O.C23H31N5O.C22H29N5O.2C22H31N5O.C20H27N5O/c1-15(2)8-20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-16-10-18(11-25-20(16)24)19-12-28(21(26-19)17-4-2-3-5-17)23-13-22(14-23,15-23)27-6-8-29-9-7-27;1-15-9-17(10-24-19(15)23)18-11-27(20(25-18)16-3-2-4-16)22-12-21(13-22,14-22)26-5-7-28-8-6-26;2*1-15(2)8-19-25-18(17-9-16(3)20(23)24-10-17)11-27(19)22-12-21(13-22,14-22)26-4-6-28-7-5-26;1-3-17-23-16(15-8-14(2)18(21)22-9-15)10-25(17)20-11-19(12-20,13-20)24-4-6-26-7-5-24/h9-11,15H,4-8,12-14H2,1-3H3;10-12,17H,2-9,13-15H2,1H3,(H2,24,25);9-11,16H,2-8,12-14H2,1H3,(H2,23,24);2*9-11,15H,4-8,12-14H2,1-3H3,(H2,23,24);8-10H,3-7,11-13H2,1-2H3,(H2,21,22) |
| InChIKey | BEDGLEDICNJXJC-UHFFFAOYSA-N |
| XLogP | 19.32 |
| TPSA | 389.18 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 170 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2324.07 |
| LogP ≤ 5 | 19.32 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 35 |